Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Thursday after the U.S. Food and Drug Administration removed Eli ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Hims & Hers (NASDAQ: HIMS) stock has done well since the company went public a few years ago. It has soared by over 193% in ...

medications, and counseling, offer hope and improved quality of life, underlining the value of professional consultation for those experiencing sexual health concerns. Like erectile dysfunction, p ...

At a hearing with the Senate Health, Education, Labor, and Pensions Committee in Washington, CEO Lars Fruergaard Jørgensen argued that the high prices of Novo Nordisk's drugs were the result of ...

In fact, all of them told me they would be able to expand coverage for these drugs if the list price was reduced," he said. The announcement preempts an argument pharmaceutical companies often ...

Second, we're expecting that as HIMS user base grows, a combination of second product use and price inflation will boost revenues on an RPU basis by about 10% YoY. This is higher than it was ...

Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to ...

Hims is also a telehealth company that offers prescription and nonprescription medication ... not obtain ED pills from websites without contact details, that offer much lower prices than ...

“90 Day Fiancé” star Ed “Big Ed” Brown says it was “love at first sight” with now-fiancée Porscha Raemond, whom he proposed to 24 hours after meeting in Plantation, Fla., last Friday.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...